ArkeaBio Raises $12M in Seed Funding


Arkea Bio, a Boston, MI-based provider of technology to reduce greenhouse gas (GHG) emissions from the agricultural sector, raised $12M in Seed funding.

The round was led by Breakthrough Energy Ventures.

The company intends to use the funds to accelerate its research program and will position itself as a leader in the global effort to decarbonize the agricultural sector.  

Led by CEO Colin South, ArkeaBio is developing an innovative vaccine to reduce methane emissions from ruminant animals (including cattle, sheep, and goats) and expects ruminant vaccinations to be one of the most scalable and cost-effective solutions to rapidly decarbonize global meat and dairy production. 

The technology will be integrated into proven delivery systems and farming practices to reduce global methane emissions from multiple ruminant species across a variety of geographies and agronomic systems.